Published in Cell Transplant on January 01, 2003
Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol (2010) 3.44
Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials (2012) 1.81
TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. Am J Physiol Cell Physiol (2006) 1.55
Role of TNF-{alpha} signaling in regeneration of cardiotoxin-injured muscle. Am J Physiol Cell Physiol (2005) 1.24
Skeletal muscle stem cells. Reprod Biol Endocrinol (2003) 1.13
TACE release of TNF-alpha mediates mechanotransduction-induced activation of p38 MAPK and myogenesis. J Cell Sci (2007) 1.07
TIMP3: a physiological regulator of adult myogenesis. J Cell Sci (2010) 1.03
Genetic variation and exercise-induced muscle damage: implications for athletic performance, injury and ageing. Eur J Appl Physiol (2016) 0.99
The effects of obesity on skeletal muscle regeneration. Front Physiol (2013) 0.93
Factor associated with neutral sphingomyelinase activity mediates navigational capacity of leukocytes responding to wounds and infection: live imaging studies in zebrafish larvae. J Immunol (2012) 0.87
Stem cell transplantation for muscular dystrophy: the challenge of immune response. Biomed Res Int (2014) 0.83
Markers of degeneration and regeneration in Duchenne muscular dystrophy. Acta Myol (2009) 0.80
Membrane versus soluble isoforms of TNF-α exert opposing effects on tumor growth and survival of tumor-associated myeloid cells. Cancer Res (2013) 0.80
Therapeutic strategies for preventing skeletal muscle fibrosis after injury. Front Pharmacol (2015) 0.80
Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles. J Neuromuscul Dis (2016) 0.75
HGF potentiates extracellular matrix-driven migration of human myoblasts: involvement of matrix metalloproteinases and MAPK/ERK pathway. Skelet Muscle (2017) 0.75
Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science (1999) 5.20
In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. Mol Cell Biol (1991) 2.70
Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol (2001) 2.06
Surgical treatment of phyllodes tumors of the breast. Cancer (1989) 1.89
Abdominal volume contribution to tidal volume as an early indicator of respiratory impairment in Duchenne muscular dystrophy. Eur Respir J (2009) 1.65
Remarkable infidelity of polymerase gammaA associated with mutations in POLG1 exonuclease domain. Neurology (2003) 1.65
Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice. Neuromuscul Disord (1997) 1.43
A CAV3 microdeletion differentially affects skeletal muscle and myocardium. Neurology (2003) 1.41
Immunocytochemistry of muscle cytoskeletal proteins in acid maltase deficiency. Muscle Nerve (1994) 1.39
Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann Neurol (1998) 1.37
Nucleus-driven multiple large-scale deletions of the human mitochondrial genome: a new autosomal dominant disease. Am J Hum Genet (1990) 1.36
Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation. Neurology (2006) 1.36
Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells. Neuropathol Appl Neurobiol (2011) 1.34
A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation. Neurology (2004) 1.33
Genetic polymorphisms for the study of multifactorial stroke. Hum Mutat (2008) 1.33
Rapid detection of the A----G(8344) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged-red fibers (MERRF). Am J Hum Genet (1991) 1.31
Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve (1994) 1.28
Stem cell therapy in stroke. Cell Mol Life Sci (2009) 1.27
Fatal infantile cytochrome c oxidase deficiency: decrease of immunologically detectable enzyme in muscle. Neurology (1985) 1.25
Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve (1992) 1.23
High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest (1994) 1.22
Prevention by anti-LFA-1 of acute myoblast death following transplantation. J Immunol (1997) 1.22
Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency. Neurology (2004) 1.22
Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis. Ann Neurol (2001) 1.21
Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol (1994) 1.20
Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals--and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers. Am J Hum Genet (1994) 1.19
Evidence of mdx mouse skeletal muscle fragility in vivo by eccentric running exercise. Muscle Nerve (1998) 1.18
TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations. Eur J Neurol (2009) 1.18
Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. Mol Ther (2001) 1.17
T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse. J Pathol (2007) 1.16
In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. Exp Cell Res (2000) 1.16
Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients. Cell Transplant (2007) 1.16
Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot-Marie-Tooth type 2. Clin Genet (2011) 1.14
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. Rejuvenation Res (2010) 1.12
Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant Proc (1992) 1.11
FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum Gene Ther (1995) 1.11
Clinical variability in Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates. Brain (1994) 1.10
Leber's hereditary optic neuropathy: genetic, biochemical, and phosphorus magnetic resonance spectroscopy study in an Italian family. Neurology (1991) 1.09
Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Gene Ther (2007) 1.08
A novel mutation in the ATP1A2 gene causes alternating hemiplegia of childhood. J Med Genet (2004) 1.07
Meganucleases can restore the reading frame of a mutated dystrophin. Gene Ther (2010) 1.07
Dystrophin expression in myotubes formed by the fusion of normal and dystrophic myoblasts. Muscle Nerve (1991) 1.05
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc (1996) 1.05
Peripheral neuropathy in mitochondrial disease. J Neurol Sci (1987) 1.05
Aging-dependent functional alterations of mitochondrial DNA (mtDNA) from human fibroblasts transferred into mtDNA-less cells. J Biol Chem (1996) 1.05
The dystrophin gene is alternatively spliced throughout its coding sequence. FEBS Lett (2002) 1.04
Chemotactic factors enhance myogenic cell migration across an endothelial monolayer. Exp Cell Res (2001) 1.04
Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection. Muscle Nerve (1994) 1.03
Novel exon 1 progranulin gene variant in Alzheimer's disease. Eur J Neurol (2008) 1.03
Non-uniform release at the frog neuromuscular junction: evidence of morphological and physiological plasticity. Brain Res (1987) 1.03
Cytochrome c oxidase deficiency. Biochem Soc Trans (1985) 1.02
Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation. Cell Transplant (1997) 1.02
Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration. Neurology (2006) 1.02
Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome. Neurology (1998) 1.02
Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations. Clin Genet (2011) 1.02
Lack of apoptosis in mitochondrial encephalomyopathies. Neurology (2001) 1.01
Progressive cytochrome c oxidase deficiency in a case of Kearns-Sayre syndrome: morphological, immunological, and biochemical studies in muscle biopsies and autopsy tissues. Ann Neurol (1987) 1.01
Effects of gender and posture on thoraco-abdominal kinematics during quiet breathing in healthy adults. Respir Physiol Neurobiol (2010) 1.00
Progress in myoblast transplantation: a potential treatment of dystrophies. Microsc Res Tech (2000) 0.99
Novel splice-site mutations and a large intragenic deletion in PLA2G6 associated with a severe and rapidly progressive form of infantile neuroaxonal dystrophy. Clin Genet (2010) 0.98
Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy. Neurology (2000) 0.98
A neurotoxic prion protein fragment induces rat astroglial proliferation and hypertrophy. Eur J Neurosci (1994) 0.97
Body building and myoglobinuria: report of three cases. Br Med J (Clin Res Ed) (1988) 0.97
Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction. Neurology (2008) 0.96
Point mutations and a large intragenic deletion in SPG11 in complicated spastic paraplegia without thin corpus callosum. J Med Genet (2009) 0.96
Induction of Anoikis following myoblast transplantation into SCID mouse muscles requires the Bit1 and FADD pathways. Am J Transplant (2007) 0.95
Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J Cell Biol (1995) 0.95
Respiratory pattern in an adult population of dystrophic patients. J Neurol Sci (2011) 0.95
Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo. Exp Cell Res (2006) 0.94
Analysis of splicing parameters in the dystrophin gene: relevance for physiological and pathogenetic splicing mechanisms. Hum Genet (2001) 0.94
Growth factors in ischemic stroke. J Cell Mol Med (2009) 0.94
Loss of Dp140 regulatory sequences is associated with cognitive impairment in dystrophinopathies. Neuromuscul Disord (2000) 0.94
Long-term balancing selection maintains trans-specific polymorphisms in the human TRIM5 gene. Hum Genet (2010) 0.93
Functional EGFP-dystrophin fusion proteins for gene therapy vector development. Protein Eng (2000) 0.93
Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype. J Med Genet (2008) 0.93
Neuroectodermal and microglial differentiation of bone marrow cells in the mouse spinal cord and sensory ganglia. J Neurosci Res (2002) 0.93
Multiple sclerosis and mitochondrial myopathy: an unusual combination of diseases. J Neurol (1994) 0.93
Acute diazepam administration produces rapid increases in brain benzodiazepine receptor density. Eur J Pharmacol (1979) 0.92
Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients. Cancer (1996) 0.92
Expression of major histocompatibility complex antigens on human myoblasts. Transplant Proc (1991) 0.92
Myoblast transplantation in whole muscle of nonhuman primates. J Neuropathol Exp Neurol (2000) 0.92
A subpopulation of murine bone marrow cells fully differentiates along the myogenic pathway and participates in muscle repair in the mdx dystrophic mouse. Exp Cell Res (2002) 0.92
Trans-acting factors may cause dystrophin splicing misregulation in BMD skeletal muscles. FEBS Lett (2003) 0.92
The apolipoprotein E epsilon4 allele causes a faster decline of cognitive performances in Down's syndrome subjects. J Neurol Sci (1997) 0.92
The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration. Eur J Neurol (2009) 0.92
Myoblast transplantation in monkeys: control of immune response by FK506. J Neuropathol Exp Neurol (1996) 0.91
Transplantation of dermal fibroblasts expressing MyoD1 in mouse muscles. Biochem Biophys Res Commun (1998) 0.91
The GST domain of GDAP1 is a frequent target of mutations in the dominant form of axonal Charcot Marie Tooth type 2K. J Med Genet (2010) 0.91
High-resolution X-ray microtomography for three-dimensional visualization of human stem cell muscle homing. FEBS Lett (2006) 0.90